Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00470626
Other study ID # 05-507
Secondary ID 110006, GTMX
Status Completed
Phase N/A
First received September 14, 2005
Last updated December 21, 2015
Start date November 2005
Est. completion date March 2009

Study information

Verified date December 2015
Source Cook
Contact n/a
Is FDA regulated No
Health authority Mexico: Federal Commission for Sanitary Risks ProtectionAustralia: Department of Health and Ageing Therapeutic Goods AdministrationGermany: Ethics CommissionSpain: Spanish Agency of Medicines
Study type Interventional

Clinical Trial Summary

The clinical study will collect data to verify the safety and performance of the Cook Celect Filter in the prevention of pulmonary embolism (PE) in patients with a temporary or permanent high risk of thromboembolism.


Recruitment information / eligibility

Status Completed
Enrollment 129
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient is at high risk for pulmonary embolism and is under consideration for placement of a permanent or short-term IVC filter.

- The patient must have a patent internal jugular vein.

- The patient or guardian must have given informed consent.

- The patient must agree to return for clinical imaging follow-up at 1, 3, 6, and 12 months.

- The patient must agree to have a clinical and imaging examination performed prior to filter retrieval.

- The patient must agree to return for clinical and imaging follow-up at 30 days and 3 months after filter retrieval.

Exclusion Criteria:

- The patient is less than 18 years of age.

- The patient is pregnant.

- The patient has uncontrollable coagulopathy.

- The patient has a life expectancy less than 6 months.

- The patient has a vena cava diameter over 30 mm, measured by vena cava sizing catheters.

- The patient's vena cava diameter is less than 15 mm, measured by vena cava sizing catheters.

- The patient has a contrast allergy that can not be adequately pre-medicated.

- The patient is simultaneously participating in another investigative drug or device study, or has a previous IVC filter.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Device:
Celect Vena Cava Filter
Effective filtration of inferior vena cava blood to prevent thromboembolism.

Locations

Country Name City State
Australia The Alfred Hospital Melbourne
Germany RWTH Aachen University Aachen
Mexico Instituto Nacional de Enfermedades Respiratorias Mexico City
Mexico Hospital Universitario de Nuevo Leon Monterrey
Spain Universitario Zaragoza - Hospital Clinico Zaragoza
United Kingdom North Hampshire Hospital Hampshire
United Kingdom Leeds Teaching Hospitals NHS Trust Leeds
United Kingdom John Radcliffe Hospital Oxford

Sponsors (5)

Lead Sponsor Collaborator
Cook Cook Ireland, Ltd., MED Institute, Incorporated, William Cook Australia, William Cook Europe

Countries where clinical trial is conducted

Australia,  Germany,  Mexico,  Spain,  United Kingdom, 

References & Publications (1)

Lyon SM, Riojas GE, Uberoi R, Patel J, Lipp ME, Plant GR, De Gregorio MA, Günther RW, Voorhees WD, McCann-Brown JA. Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry. J Vasc Interv Radiol. 2009 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Major Adverse Event Composite Major Adverse Event includes hemorrhage, perforation, pulmonary embolism, procedure-related or device-related death, occlusion, significant migration and filter fracture. up to 12 months Yes
Secondary Successful Retrieval Retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. A decision to remove a filter was made after determining that the patient no longer required the filter. Retrieval attempts were either successful (i.e., the filter was removed) or unsuccessful (i.e., the filter could not be removed and remained in the patient as a permanent device). up to 12 months No
Secondary Mean Time to Retrieval Attempt Mean time to retrieval describes the average time filters were in place in the study group before a retrieval attempt was made.
A retrieval attempt describes a procedure in which a physician tried to remove a filter from a patient. The mean time to retrieval describes the average time filters were in place before a retrieval attempt was made.
up to 12 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05050617 - Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
Terminated NCT04558125 - Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism Phase 4
Not yet recruiting NCT06017271 - Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
Completed NCT03915925 - Short-term Clinical Deterioration After Acute Pulmonary Embolism
Completed NCT02502396 - Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
Recruiting NCT05171075 - A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE Phase 3
Completed NCT04454554 - Prevalence of Pulmonary Embolism in Patients With Dyspnea on Exertion (PEDIS)
Completed NCT03173066 - Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography Phase 1
Terminated NCT03002467 - Impact Analysis of Prognostic Stratification for Pulmonary Embolism N/A
Completed NCT02334007 - Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery Phase 1/Phase 2
Completed NCT02611115 - Optimizing Protocols for the Individual Patient in CT Pulmonary Angiography. N/A
Completed NCT01975090 - The SENTRY Clinical Study N/A
Not yet recruiting NCT01357941 - Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE) N/A
Completed NCT01326507 - Prognostic Value of Heart-type Fatty Acid-Binding Protein (h-FABP) in Acute Pulmonary Embolism N/A
Completed NCT00780767 - Angiojet Rheolytic Thrombectomy in Case of Massive Pulmonary Embolism Phase 2
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00720915 - D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months N/A
Completed NCT00773448 - Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism N/A
Completed NCT00771303 - Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study
Completed NCT00816920 - Natural History of Isolated Deep Vein Thrombosis of the Calf